GTBP

GT Biopharma, Inc.

Pharmaceutical PreparationsNasdaqNon-accelerated filer<br>Smaller reporting company

Total Trades

2

Buys

2

Sells

0

Largest Trade

$15K–$50K

Insiders

2

Institutional Funds

31

Inst. Value

$100K–$500K

Activist Filings

6

Insider Trades

InsiderTitleTypeValueSharesPriceDate
Breen Michael MartinExecutive Chairman…BUY$15K–$50K50K$0.50Apr 11, 2023
Ohri ManuCFO & SecretaryBUY$15K–$50K50K$0.50Apr 10, 2023
🔓Seeing ranges? Sign in for exact trade values — free forever

Institutional Ownership

13F filings as of Dec 31, 2025 · 31 funds holding

Activist & 5%+ Owners

SC 13D/13G filings — investors holding 5%+ of outstanding shares

Bristol Investment Fund, Ltd.

SC 13G/A · Jun 2, 2025

2.4%

75K shares

Five Narrow Lane LP

SC 13G · May 14, 2025

10.0%

253K shares

CYTOVANCE BIOLOGICS INC

SC 13G/A · Oct 17, 2024

9.8%

219K shares

Armistice Capital, LLC

SC 13G/A · Feb 14, 2024

5.0%

2.2M shares

Cytovance Biologics, Inc.

SC 13G · Sep 19, 2023

6.8%

2.8M shares

Armistice Capital, LLC

SC 13G · Feb 14, 2023

10.0%

3.7M shares

View on Google Finance →